Professor | Bin Jiang | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Bin Jiang
Contact Information	binjiang@hsc.pku.edu.cn
Language ability	Chinese, English
Province	Beijing

Upload Avatar (500 x 500)

Name

Bin Jiang

Contact Information

binjiang@hsc.pku.edu.cn

Language ability

Chinese, English

Province

Beijing

University/Lab Affiliation and Title	Peking University
Faculty	Pharmaceutical Sciences
Academic Background & Achievements	PhD in Management: Renmin University of China Master's in Economics: Renmin University of China Bachelor's in Science: Beijing Normal University
Work Experience	2021.05-Present - Peking University Health Science Center, Executive Deputy Director of the Medical Technology Development and Research Center 2018.06-Present - Peking University Public Policy Research Center, Deputy Director and Researcher 2010.09-2012.02 - Harvard Medical School, Senior Visiting Scholar and Postdoctoral Fellow 2000.03-Present - Peking University School of Pharmaceutical Sciences, Lecturer and Associate Professor 1997.07-2000.02 - Beijing Medical University School of Pharmaceutical Sciences, Teaching Assistant and Lecturer

University/Lab Affiliation and Title

Peking University

Faculty

Pharmaceutical Sciences

Academic Background & Achievements

PhD in Management: Renmin University of China
Master's in Economics: Renmin University of China
Bachelor's in Science: Beijing Normal University

Work Experience

2021.05-Present - Peking University Health Science Center, Executive Deputy Director of the Medical Technology Development and Research Center
2018.06-Present - Peking University Public Policy Research Center, Deputy Director and Researcher
2010.09-2012.02 - Harvard Medical School, Senior Visiting Scholar and Postdoctoral Fellow
2000.03-Present - Peking University School of Pharmaceutical Sciences, Lecturer and Associate Professor
1997.07-2000.02 - Beijing Medical University School of Pharmaceutical Sciences, Teaching Assistant and Lecturer

Areas of Focus	Pharmaceutical Policy Decision-Making and Effect Evaluation New Healthcare Reform and Pharmaceutical Industry Development Government Regulatory Capacity Building and Evaluation
Publications	Impact of National Volume-Based Procurement on the Procurement Volumes and Spending for Antiviral Medications of Hepatitis B Virus, Jing Yuan, Z. Kevin Lu, Xiaomo Xiong, Tai-Ying Lee, Huang Huang and Bin Jiang, 2022 The impact of the reference pricing policy in China on drug procurement and cost, Bin Jiang, Ruo Jing Zhou, Xing Lin Feng, 2022 Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China, Jing Yuan, Z Kevin Lu, Xiaomo Xiong, Bin Jiang, 2021 Does pre-operative halo-gravity traction reduce the degree of deformity and improve pulmonary function in severe scoliosis patients with pulmonary insufficiency? A systematic review and meta-analysis, Zhao Yang, Yang Liu, Longtao Qi, Shanshan Wu, Jingwen Li, Yu Wang, Bin Jiang, 2021 Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis, Lu ZK, Xiong X, Lee T, Wu J, Yuan J, Jiang B, 2021 Mobile Apps for Drug–Drug Interaction Checks in Chinese App Stores: Systematic Review and Content Analysis, Chunying Shen, Bin Jiang, Qilian Yang, Chengnan Wang, Kevin Z Lu, 2021 Age and Gender Disparities in Adverse Events Following COVID-19 Vaccination: Real-World Evidence Based on Big Data for Risk Management, Xiaomo Xiong, Jing Yuan, Minghui Li, Bin Jiang, Kevin Lu, 2021 Physicians’ Knowledge, Altitudes, and Perceived Barriers of Inappropriate Prescribing for Older Patients in Shanghai, China, Jing Yuan, Guizhi Yin, Meng Gu, Kevin Z. Lu, Bin Jiang and Minghui Li, 2022 Impact of financial barriers on health status, healthcare utilization and economic burden among individuals with cognitive impairment: a national cross-sectional survey, Lu ZK, Xiong X, Horras A., Jiang B. M Li, 2022 国家组织药品带量采购政策的控费效果及其影响因素研究, 周若婧，江滨, 2022 The effects of the national drug pooled procurement (NDPP) pilot program in China, Ningtai Luo, Jianying Yue, Ruojing Zhou, Bin Jiang, 2022 准公共产品视域下的城乡居民基本医保服务地区间均等性评价, 周若婧, 黄璜, 江滨, 2022

Areas of Focus

Pharmaceutical Policy Decision-Making and Effect Evaluation
New Healthcare Reform and Pharmaceutical Industry Development
Government Regulatory Capacity Building and Evaluation

Publications

Impact of National Volume-Based Procurement on the Procurement Volumes and Spending for Antiviral Medications of Hepatitis B Virus, Jing Yuan, Z. Kevin Lu, Xiaomo Xiong, Tai-Ying Lee, Huang Huang and Bin Jiang, 2022
The impact of the reference pricing policy in China on drug procurement and cost, Bin Jiang, Ruo Jing Zhou, Xing Lin Feng, 2022
Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China, Jing Yuan, Z Kevin Lu, Xiaomo Xiong, Bin Jiang, 2021
Does pre-operative halo-gravity traction reduce the degree of deformity and improve pulmonary function in severe scoliosis patients with pulmonary insufficiency? A systematic review and meta-analysis, Zhao Yang, Yang Liu, Longtao Qi, Shanshan Wu, Jingwen Li, Yu Wang, Bin Jiang, 2021
Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis, Lu ZK, Xiong X, Lee T, Wu J, Yuan J, Jiang B, 2021
Mobile Apps for Drug–Drug Interaction Checks in Chinese App Stores: Systematic Review and Content Analysis, Chunying Shen, Bin Jiang, Qilian Yang, Chengnan Wang, Kevin Z Lu, 2021
Age and Gender Disparities in Adverse Events Following COVID-19 Vaccination: Real-World Evidence Based on Big Data for Risk Management, Xiaomo Xiong, Jing Yuan, Minghui Li, Bin Jiang, Kevin Lu, 2021
Physicians’ Knowledge, Altitudes, and Perceived Barriers of Inappropriate Prescribing for Older Patients in Shanghai, China, Jing Yuan, Guizhi Yin, Meng Gu, Kevin Z. Lu, Bin Jiang and Minghui Li, 2022
Impact of financial barriers on health status, healthcare utilization and economic burden among individuals with cognitive impairment: a national cross-sectional survey, Lu ZK, Xiong X, Horras A., Jiang B. M Li, 2022
国家组织药品带量采购政策的控费效果及其影响因素研究, 周若婧，江滨, 2022
The effects of the national drug pooled procurement (NDPP) pilot program in China, Ningtai Luo, Jianying Yue, Ruojing Zhou, Bin Jiang, 2022
准公共产品视域下的城乡居民基本医保服务地区间均等性评价, 周若婧, 黄璜, 江滨, 2022

Pharmaceutical Policy Decision-Making Effect Evaluation Healthcare Reform Pharmaceutical Industry Development Government Regulatory Capacity Building Evaluation

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us